/

(sepsis/septic
shock)

(MAPCVP
ScvO2UOP)

(ACS)

(heart failure)

(ARDS)

(
)

-
- (WBC
CRPPro-Cal)
- (lactate
UOP
)
- (Cre
ASTPT/aPTT)
SOFA

(/
)/
(
)

- (JVD
HJRS3)
-
(BNPNT-pro
BNPTnI)
- CXR (
)
-
12

(
)
(
)

(--/
)

- 12 (T
ST /
)
- (6
CK-MB/TnI)
- /
TIMI
CRUSADE

- (PaO2/
FiO2< 200)
- CXR

- (

(ARDS)
(
/
)

: (
)
(dopamine
norepinephrine)
CVP 8-12
mmHgMAP >65
mmHgScvO2 >70%
:
(
/
/)
:
(hydrocortisone
200-300 mg IV/IVF)?

drotrecogin alfa
(24 mcg/kg IVF 96
hrs)?
(
<150mg/dl)

NIPPV

(IVB IVF

)morphine

(dobutamine
levosimendan)

(NTG IVF)

(TZD
NSAID
CCB
)

(TvPplat
pCO2PEEP)

(cisatracurium
IVF)

? (?)

(EPA/GLA)/
(glutamine)

NO

PEEP

(
)

) (

)
MONA
(morphineO2
NTGaspirin)
A (
) aspirin
clopidogrel
UFH
GPIIb/IIIa
B (
)C ()D
()E ()

(
NACNaHCO3
?
NSAIDmetformin)
/

(HITIABP)
HIT

(acute liver
failure)

/)

(cirrhosis)

(ARF)

(atrial fibrillation)

(acute
pancreatitis)
/

(ARDSMODS)

(status
epilepticus)

)
/

(
)/

- /
/
- //

-
-
(ANAASMA
anti-KLM1)

- //

-
SAAG

- /
/
- FENa
(
FEUN)
-
AG (Na-CI-HCO3)

- 12
( P
)
- /
(K Mg)/
- (

PTHLVEF)
CHADS2

- Cullen
Turner

- amylase/lipase
x3 ULNgluCa
Ransons
criteria

()
/ (

) (
)

(CaCl2NaHCO3
D50W

)
(

(IHDCVVH
SLEED)

()
(
)

()

()
- (Na)/
()
- (
)
- (
)
-

()
(
)

(
)
(
)

()

(Vit. K1
FFP/Plt/Cyro
RFVIIa)
(
Na
145-155
mEq/Lmannitol)

- NAC &
acetaminophen
- &

-
(penicillamine)
(Zn
acetate)
Wilsons Dz
MARS

(Vit. K1
FFP/Plt/Cyro
RFVIIa)

(Lactulose/lacitol
neomycin?
flumazenil)
[Alb
(furosemide
spironolactone)
LVP]

[terlipressin (
)
()]

[Alboctreotide/
terlipressin
midodrine)

60-80 bpm [CCB

(diltiazem
verapamil)
digoxin]

(amiodarone
dronedarone)
(

)
aspirin
warfarin (INR 2-3)
dabigatran

(UOP>0.5ml/kg/hr)

(fentanyl IVF)

(imipenem/
meropenem)

(gabexate
mesylate)
?

(
TPN
)

thiamineD50W
BZD
(lorazepam
midazolam)

(phenytoin/
fosphenytoin
valproate
phenobarbital
propofol)
[]
(thiopental
thiamylal sodium)


(intracranial
hypertension)

(ICH)

(SAH)

(74%)/

- CT (

) X
- GCS
(CushingHRBP)
-

- GCS
- CT (

)
- (

()()
(
)

:
CPP (MAP - ICP)
>70 mmHg ICP
<20~25 mmHg
30

(mannitol 0.25~1
g/kg IVD
<320
mOsm)(3% NaCl
40~50 ml/hr Na
140~160 mEq/L)

(propofol 5~80
mcg/kg/min
thiopental 2 mg/kg
IVB 1 mg/kg/hr)

(NEJM. 2014;370:
2121-30.)

G
S

(healthcareassociated
pneumonia)

(stress ulcer)

(DVT)

(MG)

(COPD acute
exacerbation)

/
/

()

/
(
)

- GCS
- CT
- (
III [PCA] VI
[IICP]
[ACA]

[MCA])

-
(COPDTB
)
- X (
)
-

- Hb/Hct (
12 )
-
-

- Edrophonium
(Tensilon)
- Anti-AChR Ab (+)
-
- CT (
)
- (NIF
FVC)
-

-
- ABG
(PCO2
PO2SaO2)
- X
-
(FEV1FVC)

()()
(
/)

()

()

(ABC)

(nimodipine 0.5~2
mg/hr IVF)
Triple H (
)

(
mannitol
0.25~1 g/kg IVD
/
)

(cerebral salt
wasting)NS 3%
NaCl
0.5~1 mEq/L/hr
CPM

:
macrolide + 3rdgen cephFQ
(
Streptococcus
pneumoniaS.
aureusGNB
Mycoplasma
ChlamydiaH.
influenza
Legionella,
Klebsiella)
:
(>65
)
30

(chlorhexidine)

()
(

AGs)

IVIG

(
)

(ABC)
warfarin
Vit.
K1FFP (Factor
VIIa
[NovoSeven RT]
10-100 mcg/kg IV
Q2H)

(SBP 140 mmHg)

(SBP
180 mmHg)

(
)
(NSAID
)

(ABC)
()

(
)

(sucralfate
H2RAPPI)
PPI
H2RA
PPI
H2RA

PPI

-
(protein C/S
antithrombin)
- D-dimer (<500
ng/ml DVT)
-
-
-

(
)
(
)
UFH 80
U/kg ( 5000 U)
18 U/kg (aPTT
1.5~2.5x)
enoxaparin 1
mg/kg SQ Q12H

UFH 5000 U SQ
Q8~12H
enoxaparin 40
mg QD 30mg
BIDdabigatran
110 mg BID
warfarin (INR
2-3)

2A
ipratropiumIV

( [
]
)

3~7 (
H. influenza
S. pneumonia,
M. catarrhalis,
Pseudomonas)

BODE index
(NEJM.
2004;350:
1005-12.)

(hypertensive
emergency)

(cardiogenic shock)

(/

//
)
-

(BP >180/120
mmHg)
(
)
- CT
-

()

()
(MAOI

(ABC)

(NTG
nicardipine
labetaol)
MAP
25% ( 2
)DBP
10~15%<110
mmHg ( 2~6
)

SBP 120 mmHg

(5~10 )

()

-
(BP)
-
(UOPSVR
PCWPCVP)
-
(ST
TnI/TnT)
- (
)

(ABC)

tPA
/

(dopamine
norepinephrine)
PCWP 15~20
mmHgMAP >60
mmHg
:
dobutamine
levosimendan

(IABP)